0001127602-13-005619.txt : 20130212 0001127602-13-005619.hdr.sgml : 20130212 20130212170839 ACCESSION NUMBER: 0001127602-13-005619 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130208 FILED AS OF DATE: 20130212 DATE AS OF CHANGE: 20130212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILLIAMS DOUGLAS E CENTRAL INDEX KEY: 0001184847 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 13598126 MAIL ADDRESS: STREET 1: C/O AMGEN INC STREET 2: ONE AMGEN CENTER DR CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-02-08 0000875045 BIOGEN IDEC INC. BIIB 0001184847 WILLIAMS DOUGLAS E BIOGEN IDEC INC. 133 BOSTON POST ROAD WESTON MA 02493 1 EVP Research & Development Common Stock 2013-02-08 4 M 0 3006 0 A 10191 D Common Stock 2013-02-08 4 F 0 1252 164.44 D 8939 D Restricted Stock Unit 0 2013-02-08 4 M 0 3006 0 D 2016-02-08 Common Stock 3006 10869 D Restricted Stock Unit 0 2013-02-08 4 J 0 462 0 D 2016-02-08 Common Stock 462 10407 D The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]). This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. Aras Lapinskas, Attorney in Fact for Douglas E. Williams 2013-02-12